A gene for congenital generalized lipodystrophy maps to human chromosome 9q34

被引:99
|
作者
Garg, A
Wilson, R
Barnes, R
Arioglu, E
Zaidi, Z
Gurakan, F
Kocak, N
O'Rahilly, S
Taylor, SI
Patel, SB
Bowcock, AM
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA
[3] NIDDKD, Diabet Branch, Bethesda, MD 20892 USA
[4] Zinnah Postgrad Med Ctr, Dept Dermatol, Karachi, Pakistan
[5] Hacettepe Univ, Fac Med, Dept Pediat, Gastroenterol Unit, TR-06100 Ankara, Turkey
[6] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
[7] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QQ, England
来源
关键词
D O I
10.1210/jc.84.9.3390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital generalized lipodystrophy (CGL, Berardinelli-Seip Syndrome, OMIM # 269700) is a rare autosomal recessive disorder characterized by near complete absence of adipose tissue from birth. Affected individuals have marked insulin resistance, hypertriglyceridemia and acanthosis nigricans, and develop diabetes mellitus during teenage years. The genetic defect for CGL is unknown. A semi-automated genome-wide scan with a set of highly polymorphic short tandem repeats (STR) was carried out in 17 well-characterized pedigrees and identified a locus for CGL to chromosome 9q34. The maximum two-point lod score obtained was 3.6 at D9S1818 (theta(max) = 0.05). There was evidence for genetic heterogeneity (alpha = 0.73) and 2 of the pedigrees were unlinked. Multipoint linkage analysis excluding the 2 unlinked families yielded a peak lod score of 5.4 between loci D9S1818 and D9S1826. The CGL1 critical region harbors a plausible candidate gene encoding the retinoid X receptor alpha (RXRA) that plays a central role in adipocyte differentiation. Identification of the CGL gene(s) will contribute to our understanding of the adipocyte differentiation and elucidation of the mechanisms of insulin resistance in disorders of adipose tissue.
引用
收藏
页码:3390 / 3394
页数:5
相关论文
共 50 条
  • [31] ASSIGNMENT OF PP14 (PLACENTAL PROTEIN-14) GENE TO CHROMOSOME-9, ON 9Q34 AND DISTAL TO ABL
    BERNHEIM, A
    GROSS, M
    VAISSE, C
    SLIM, R
    MILGROM, E
    NGUYEN, VC
    GROSS, M
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 1935 - 1935
  • [32] HAMARTOMAS FROM PATIENTS WITH TUBEROUS SCLEROSIS SHOW LOSS OF HETEROZYGOSITY FOR CHROMOSOME 9Q34
    GREEN, AJ
    SEPP, T
    YATES, JRW
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (02) : 152 - 153
  • [33] A gene for freckles maps to chromosome 4q32-q34
    Zhang, XJ
    He, PP
    Liang, YH
    Yang, S
    Yuan, WT
    Xu, SJ
    Huang, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (02) : 286 - 290
  • [34] LASER MICRODISSECTION AND ITS APPLICATION TO TSC1 REGION ON CHROMOSOME 9Q34
    HE, W
    SMITH, M
    HANDA, K
    BERNS, MW
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1508 - 1508
  • [35] Analysis of the VAV2 and bromodomain homeotic gene region on chromosome 9q34 center dot 3.
    Smith, M
    Handa, K
    ANNALS OF HUMAN GENETICS, 1997, 61 : 223 - 224
  • [36] CHRONIC MYELOGENOUS LEUKEMIA AND BREAKS AT 9Q34
    LEWIS, JP
    MEYERS, FJ
    CANCER GENETICS AND CYTOGENETICS, 1985, 17 (04) : 367 - 368
  • [37] Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood?
    Cormier-Daire, V
    Molinari, F
    Rio, M
    Raoul, O
    de Blois, MC
    Romana, S
    Vekemans, M
    Munnich, A
    Colleaux, L
    JOURNAL OF MEDICAL GENETICS, 2003, 40 (04) : 300 - 303
  • [38] Comparative mapping of the TSC1 region of chromosome 9q34 in fugu rubripes using the human ATS-V gene.
    Ali, JBM
    Clark, M
    Furlong, R
    Green, AJ
    ANNALS OF HUMAN GENETICS, 1997, 61 : 207 - 207
  • [39] ASSIGNMENT OF THE HUMAN TEAR LIPOCALIN GENE (LCN1) TO 9Q34 BY IN-SITU HYBRIDIZATION
    LASSAGNE, H
    RESSOT, C
    MATTEI, MG
    GACHON, AMF
    GENOMICS, 1993, 18 (01) : 160 - 161
  • [40] Mutation of the 9q34 gene TSC1 in sporadic bladder cancer
    Hornigold, N
    Devlin, J
    Davies, AM
    Aveyard, JS
    Habuchi, T
    Knowles, MA
    ONCOGENE, 1999, 18 (16) : 2657 - 2661